IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Developing controlled-release formulations of approved drugs for ADHD and narcolepsy.
Industry: Health Care
Latest Trade: $0.70 0.00 (0.0%)
First Day Return: -30.4%
Return from IPO: -83.2%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 02/28/2020 |
Offer Price | $4.15 |
Price Range $5.00 - $6.00 | |
Offer Shares (mm) | 4.8 |
Deal Size ($mm) | $20 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 01/28/2021 |
Offer Price | $4.15 |
Price Range $5.00 - $6.00 | |
Offer Shares (mm) | 4.8 |
Deal Size ($mm) | $20 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Maxim Group LLC |
Brookline Capital Markets |
Company Data | |
---|---|
Headquarters | Stans, Switzerland |
Founded | 2015 |
Employees | 5 |
Website www.nlspharma.com |